From prostate-specific antigen to precision: The future of prostate cancer diagnosis with artificial intelligence, biomarkers, and imaging

Background:. Prostate cancer (PCa) diagnosis has historically relied on prostate-specific antigen (PSA) testing. Although PSA screening significantly reduces mortality rates, it is limited by its low specificity and the risk of overdiagnosis and overtreatment. These limitations highlight the need fo...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Helena Margot Flôres Soares da Silva, Juan Gómez Rivas, Paula Mata Déniz, María Jesús Marugan, Claudia González-Santander, Lorena Fernández Montarroso, Isabel Galante, Jesús Moreno Sierra
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wolters Kluwer Health 2026-05-01
Ráidu:	Current Urology
Liŋkkat:	http://journals.lww.com/10.1097/CU9.0000000000000326
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!